Arulanandam, A.; Lin, L.; Chang, H.-M.; Cerutti, M.; Choblet, S.; Gao, P.; Rath, A.; Bensussan, A.; Kadouche, J.; Teper, D.;
et al. Derivation and Preclinical Characterization of CYT-303, a Novel NKp46-NK Cell Engager Targeting GPC3. Cells 2023, 12, 996.
https://doi.org/10.3390/cells12070996
AMA Style
Arulanandam A, Lin L, Chang H-M, Cerutti M, Choblet S, Gao P, Rath A, Bensussan A, Kadouche J, Teper D,
et al. Derivation and Preclinical Characterization of CYT-303, a Novel NKp46-NK Cell Engager Targeting GPC3. Cells. 2023; 12(7):996.
https://doi.org/10.3390/cells12070996
Chicago/Turabian Style
Arulanandam, Antonio, Liang Lin, Hao-Ming Chang, Martine Cerutti, Sylvie Choblet, Peng Gao, Armin Rath, Armand Bensussan, Jean Kadouche, Daniel Teper,
and et al. 2023. "Derivation and Preclinical Characterization of CYT-303, a Novel NKp46-NK Cell Engager Targeting GPC3" Cells 12, no. 7: 996.
https://doi.org/10.3390/cells12070996
APA Style
Arulanandam, A., Lin, L., Chang, H.-M., Cerutti, M., Choblet, S., Gao, P., Rath, A., Bensussan, A., Kadouche, J., Teper, D., Mandelboim, O., & Li, W.
(2023). Derivation and Preclinical Characterization of CYT-303, a Novel NKp46-NK Cell Engager Targeting GPC3. Cells, 12(7), 996.
https://doi.org/10.3390/cells12070996
